MetLife (MET)

EBITDA Growth

-11.73%

TTM · Period ending:

MET logo

MET EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-11.73%
MET TTM EBITDA YoY % (455.92% → -11.73%)
High-resolution chart · PNG

MET ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

MetLife EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-11.7299%
-15.5128%
-14.0712%
-3.9653%
41.3439%
73.8761%
107.6395%
56.8228%
-1.0358%
-25.2288%
-54.2053%
-39.4328%
-32.8277%
-49.8924%
-22.5846%
-17.0923%
5.9882%
328.5084%
15.3827%
3.629%
-28.594%
-78.5684%
1.1613%
-25.85%
10.0742%
55.8875%
4.3209%
70.7131%
58.1882%
39.6632%
56.137%
3,867.1053%
563.382%
2,050.7299%
196.4486%
-97.5927%
-88.8011%
-103.2028%
-81.505%
-34.3386%
-29.4095%
-23.8811%
-13.3932%
4.0918%
42.7512%
90.3625%
87.8515%
155.617%
339.8551%
31.9624%
85.4659%
-15.224%
-84.2196%
-48.851%
-72.6095%
-52.2834%
150.8726%
75.01%
115.65%
66.8036%
13.4527%
476.9231%
229.7362%
294.7636%
8,479.5455%
-137.5106%
-152.9636%
-135.3017%
-100.5847%
-56.3095%
-16.0824%
-0.8149%
-3.8584%
15.9667%
63.5483%
61.3725%
75.4146%
39.4285%
2.685%
2.3769%
-4.8817%
17.5476%
26.5861%
19.6577%
31.2168%
32.9897%
51.8929%
89.5515%
94.2935%
107.5875%
60.9231%
110.2307%
185.2713%
136.5031%
301.2346%
-20.9984%
-77.8122%
-74.9808%
-85.7143%
-58.6501%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.